Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.
about
Survival from XDR-TB is associated with modifiable clinical characteristics in rural South AfricaThe whole is greater than the sum of the parts: recognising missed opportunities for an optimal response to the rapidly maturing TB-HIV co-epidemic in South AfricaThe experience of "medicine companions" to support adherence to antiretroviral therapy: quantitative and qualitative data from a trial population in UgandaDisclosure of HIV status: Experiences of Patients Enrolled in an Integrated TB and HAART Pilot Programme in South Africa.AtriplaR/anti-TB combination in TB/HIV patients. Drug in focusExtensively drug-resistant tuberculosis: a new face to an old pathogen.Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community.Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections.Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of careMultidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation.Prevalence and predictors of tuberculosis coinfection among HIV-seropositive patients attending the Aminu Kano Teaching Hospital, northern Nigeria.
P2860
Q28481405-0728325C-00AC-4750-955B-3218E59D976EQ33483082-A00D09F1-CDA7-451A-8BA7-9A0321214168Q33648147-DC1143D4-4D9F-4458-8441-3025CD8B7253Q33799485-F18FFAD7-6191-427E-B069-C817F0A0E6ACQ34083071-C62D8B8D-333E-420C-A23D-0D40C21CF9CEQ34453677-74B6D788-A72A-4906-B4EC-5245E4A1B3E5Q34453683-A325AD5D-36CB-4459-9440-9357CE1A137BQ35905025-5C754548-13AF-4F09-83E7-3863A25AE7F8Q36078264-477D60BC-E9F9-422A-9740-CF3C87E85F4BQ37053021-BE64A492-0EED-48E6-A41A-8F60544A2219Q37395017-A3D69AC0-C8D3-491B-BF73-CF8F48C65246Q37583228-671A7A30-1376-4A4A-B7C3-64C5EF9AEF22
P2860
Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Utility of tuberculosis direct ...... in resource-limited countries.
@en
type
label
Utility of tuberculosis direct ...... in resource-limited countries.
@en
prefLabel
Utility of tuberculosis direct ...... in resource-limited countries.
@en
P2093
P50
P356
P1476
Utility of tuberculosis direct ...... in resource-limited countries.
@en
P2093
Christopher Jack
Gerald Friedland
Neel Gandhi
Umesh Lalloo
P304
P356
10.1086/421407
P407
P478
38 Suppl 5
P577
2004-06-01T00:00:00Z